Madeleine Duvic is a Dermatology physician affiliated with Cancer Clinic. OpenAlex indexes 896 publications with 44,538 citations (h-index 101); ClinicalTrials.gov lists 9 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6655 Travis St
600
Houston, TX 770301312
Telephone
713-500-8260Registry record last updated 3 Dec 2007.
Clinical trials
- CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)
Sponsor: M.D. Anderson Cancer Center
- Trial of Curcumin in Cutaneous T-cell Lymphoma Patients
Sponsor: M.D. Anderson Cancer Center
- Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Sponsor: Spectrum Pharmaceuticals, Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Kyowa Kirin, Inc.Program year20231 payment
- Bausch Health US, LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
21.2%Corticosteroid18.2%Triamcinolone Acetonide100%Part D≥74 patientsRetinoid3%Acitretin100%Part D<11 patientsAnti-infectives
17.4%Azole Antifungal9%Ketoconazole100%Part D≥34 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor3.2%Valacyclovir100%Part D<11 patients+ 2 more classes in this area
Cancer & immunology
16.5%Retinoid13.4%Bexarotene100%Part D≥17 patientsAlkylating Drug3%Valchlor100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 1986–2004 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Journal of Cutaneous Pathology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”